Inflammation is a physiological response to infection or injury and involves the innate and adaptive immune system. Tanshinone IIA (Tan IIA) is a well-known flavonoid that elicits an important therapeutic effect by inhibiting inflammatory response. In this study, we examined whether Tan IIA exerts anti-inflammatory activity and investigated the possible mechanisms, including Toll-like receptor 4 (TLR4)–MyD88–nuclear factor kappa B (NF-κB) signaling pathway and microRNA expression in lipopolysaccharide (LPS)-induced RAW264.7 cells. Tan IIA could attenuate the inflammatory reaction via decreasing cytokine, chemokine, and acute-phase protein production, including GM-CSF, sICAM-1, cxcl-1, MIP-1α, and tumor necrosis factor alpha (TNF-α), analyzed by Proteome profile array in LPS-induced RAW264.7 cells. Concurrently, the messenger RNA (mRNA) expressions of IL-1β, TNF-α, and COX-2 were also significantly reduced by Tan IIA. Additionally, Tan IIA decreased LPS-induced NF-κB activation and downregulated TLR4 and MyD88 protein expression levels. We also observed reduced microRNA-155, miR-147, miR-184, miR-29b, and miR-34c expression levels, while LPS-induced microRNA-105, miR-145a, miR-194, miR-383, miR-132, and miR-451a expression levels were upregulated using microRNA (miRNA) qPCR array. Our results indicate that Tan IIA could exert an anti-inflammatory effect on LPS-induced RAW264.7 cells by decreasing TLR4–MyD88–NF-κB signaling pathway and regulating a series of cytokine production and miRNA expression.
This is a preview of subscription content, log in to check access.
We are grateful for the financial support from the National Key Basic Research Program of China (2012CB518404), the National Natural Science Foundation of China (81273891), the National Science Fund for Distinguished Young Scholars (81125024), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1276).
Conflict of Interest
The authors declare no competing financial interest.
Zheng, S., Z. Ren, Y. Zhang, and Y. Qiao. 2014. Anti-inflammatory mechanism research of tanshinone IIA by module-based network analysis. Biomed Mater Eng. 24: 3815–3824.PubMedGoogle Scholar
You, Z., Y. Xin, Y. Liu, B. Han, L. Zhang, Y. Chen, Y. Chen, L. Gu, H. Gao, and Y. Xuan. 2012. Protective effect of Salvia miltiorrhizae injection on N (G)-nitro-D-arginine induced nitric oxide deficient and oxidative damage in rat kidney. Exp Toxicol Pathol. 64: 453–458.CrossRefPubMedGoogle Scholar
Li, Y., Y. Guo, Y. Chen, Y. Wang, Y. You, Q. Yang, X. Weng, Q. Li, X. Zhu, B. Zhou, X. Liu, Z. Gong, and R. Zhang. 2015. Establishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep 12: 1665–1676.PubMedCentralPubMedGoogle Scholar
Tang, C., H. Xue, C. Bai, R. Fu, and A. Wu. 2010. The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine. 17: 1145–1149.CrossRefPubMedGoogle Scholar
Chen, Y., X. Wu, S. Yu, X. Lin, J. Wu, L. Li, J. Zhao, and Y. Zhao. 2012. Neuroprotection of Tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. PLoS ONE 7: e40165.PubMedCentralCrossRefPubMedGoogle Scholar
He, H., H. Tang, L. Gao, Y. Wu, Z. Feng, H. Lin, and T. Wu. 2015. Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats. Mol Med Rep. 11: 4190–4196.PubMedCentralPubMedGoogle Scholar
Xu, M., F.L. Cao, Y.F. Zhang, L. Shan, X.L. Jiang, X.J. An, W. Xu, X.Z. Liu, and X.Y. Wang. 2015. Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice. Acta Pharmacol Sin 36: 179–187.PubMedCentralCrossRefPubMedGoogle Scholar
O'Connell, R.M., D.S. Rao, A.A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 10: 111–122.CrossRefPubMedGoogle Scholar
Huffaker, T.B., R. Hu, M.C. Runtsch, E. Bake, X. Chen, J. Zhao, J.L. Round, D. Baltimore, and R.M. O'Connell. 2012. Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep 2: 1697–1709.PubMedCentralCrossRefPubMedGoogle Scholar
Zhang, Y., R. Yan, and Y. Hu. 2015. Oxymatrine inhibits lipopolysaccharide-induced inflammation by down-regulating Toll-like receptor 4/nuclear factor-kappa B in macrophages. Can J Physiol Pharmacol 93: 253–260.CrossRefPubMedGoogle Scholar
Colotta, F., P. Allavena, A. Sica, C. Garlanda, and A. Mantovani. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073–1081.CrossRefPubMedGoogle Scholar
Tu, J., Y. Xing, Y. Guo, F. Tang, L. Guo, and T. Xi. 2012. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. Int Immunopharmacol. 14: 353–361.CrossRefPubMedGoogle Scholar
Aviram, M. 2000. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res. 33: S85–S97.PubMedGoogle Scholar
Fan, G.W., X.M. Gao, H. Wang, Y. Zhu, J. Zhang, L.M. Hu, Y.F. Su, L.Y. Kang, and B.L. Zhang. 2009. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol. 113: 275–280.CrossRefPubMedGoogle Scholar
Xu, Y., D. Feng, Y. Wang, S. Lin, and L. Xu. 2008. Sodium Tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1pathways. J Clin Immunol. 28: 512–519.CrossRefPubMedGoogle Scholar
Murray, P.J., and T.A. Wynn. 2001. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 11: 723–737.CrossRefGoogle Scholar
Pascual, G., A.L. Fong, S. Ogawa, A. Gamliel, A.C. Li, V. Perissi, D.W. Rose, T.M. Willson, M.G. Rosenfeld, and C.K. Glass. 2005. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 437: 759–763.PubMedCentralCrossRefPubMedGoogle Scholar
Yuan, Z., M.A. Syed, D. Panchal, D. Rogers, M. Joo, and R.T. Sadikot. 2012. Curcumin mediated epigenetic modulation inhibits TREM-1 expression in response to lipopolysaccharide. Int J Biochem Cell Biol. 44: 2032–2043.CrossRefPubMedGoogle Scholar
Zhang, X., G. Wang, E.C. Gurley, and H. Zhou. 2014. Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS One. 9: e107072.PubMedCentralCrossRefPubMedGoogle Scholar
Asirvatham, A.J., C.J. Gregorie, Z. Hu, W.J. Magner, and T.B. Tomasi. 2008. MicroRNA targets in immune genes and the Dicer/argonaute and ARE machinery components. Mol. Immunol. 145: 1995–2006.CrossRefGoogle Scholar
Martinez, R.T., F. Louafi, P.S. Friedmann, and T. Sanchez. 2009. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem. 284: 16334–16342.CrossRefGoogle Scholar
Yang, L.L., J.Q. Liu, X.Z. Bai, L. Fan, F. Han, W.B. Jia, L.L. Su, J.H. Shi, C.W. Tang, and D.H. Hu. 2014. Acute downregulation of miR-155 at wound sites leads to a reduced fibrosis through attenuating inflammatory response. Biochem Biophys Res Commun 453: 153–159.CrossRefPubMedGoogle Scholar
Zheng, Y., S. Xiong, P. Jiang, R. Liu, X. Liu, J. Qian, X. Zheng, and Y. Chu. 2012. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med 52: 1307–1317.CrossRefPubMedGoogle Scholar
Fu, Y., B. Liu, N. Zhang, Z. Liu, D. Liang, F. Li, Y. Cao, X. Feng, X. Zhang, and Z. Yang. 2013. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways. J Ethnopharmacol. 145: 193–199.CrossRefPubMedGoogle Scholar
Murata, T., S. Kohno, C. Ito, M. Itoigawa, A. Sugiura, K. Hikita, and N. Kaneda. 2013. Inhibitory effect of carbazolequinone derivatives on lipopolysaccharide and interferon-γ-induced nitric oxide production in mouse macrophage RAW264.7 cells. J Pharm Pharmacol 65: 1204–1213.CrossRefPubMedGoogle Scholar
Saccani, S., S. Pantano, and G. Natoli. 2011. Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193: 1351–1360.CrossRefGoogle Scholar
O'Connell, R.M., K.D. Taganov, M.P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104: 1604–1609.PubMedCentralCrossRefPubMedGoogle Scholar
Bandyopadhyay, S., M.E. Long, and L.A. Allen. 2014. Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response. PLoS One 9: e109525.PubMedCentralCrossRefPubMedGoogle Scholar